The Efficacy of VR and AR on Pruritus

Hacettepe University47 enrolled

Overview

The research will be conducted randomly in order to determine the effect of VR and AR on pruritus symptom.

In this study, there will be three groups: intervention group 1 with autogenic relaxation (AR), intervention group 2 with virtual reality (VR) game application and control group with routine nursing care and kidney functions narration. The number of volunteers to be included in the study was determined by power analysis. Forty patients with itch symptoms will be included in each group. Preliminary application for all three groups will be performed in the patient group registered to the Dialysis Unit of the Nephrology Department of Hacettepe University and Baskent University Hospital. Socio-Demographic Form, 5-D Itch Scale, Dermatology Life Quality Index, State and Trait Anxiety Scale, Pruritus Behavior and SGO / OR Application Log.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Chronic Renal Insufficiency Pruritus Itch

Interventions

Autogenic RelaxationOTHER

Autogenic relaxation

virtual reality game applicationOTHER

virtual reality game application,

kidney function narrationOTHER

kidney function narration

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Receiving hemodialysis treatment for the last 6 months, * Receiving four hour hemodialysis treatment three times a week, * 18-65 years of age, * experiencing pruritus for the last month. * Not taking any pharmacological / non-pharmacological treatment for pruritus * No cognitive and psychiatric diagnosis, * Do not use hearing aids, * Open to communication and cooperation, * Using smart mobile phone, * Without liver disease and dermatological diseases, * Patients who agree to participate in the study will be included in the study. Exclusion Criteria: * Pregnant in the research process, * Kidney transplantation, * Experiencing discomfort due to virtual reality glasses, * Patients who voluntarily leave the trial will be excluded from the follow-up.

Locations (1)

Neşe Altinok Ersoy

Ankara, Eyalet/Yerleşke, Turkey (Türkiye)

Outcomes

Primary Outcomes

5-D Itch Scale

The score obtained from information about itching severity, frequency, and its effect on daily life activities.

Time frame: Assessing change of 5-D Itch Scale scores baseline, first, fifth and seventh weeks.

Secondary Outcomes

Dermatology Life Quality Index

The scale gives an information about quality of life

Time frame: Assessing change of Dermatology Life Quality Index scores baseline, first, fifth and seventh weeks. .

State-Trait Anxiety Inventory

The scale gives an information about anxiety

Time frame: Assessing change of State-Trait Anxiety Inventory scores baseline, first, fifth and seventh weeks.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.